N. Oku et al., APPLICATION OF LONG-CIRCULATING LIPOSOMES TO CANCER PHOTODYNAMIC THERAPY, Biological & pharmaceutical bulletin, 20(6), 1997, pp. 670-673
Photodynamic therapy (PDT) as a cancer treatment is notable for its qu
ite low side effects in comparison with those of chemotherapy and radi
otherapy. However, the accumulation of porphyrin derivatives used in P
DT into tumor tissues is rather low. Since long-circulating liposomes
are known to accumulate passively into tumor tissues, we liposomalized
a porphyrin derivative, benzoporphyrin derivative monoacid ring A (BP
D-MA), and used these liposomes to investigate the usefulness of PDT f
or tumor-bearing mice. BPD-MA was liposomalized into glucuronate-modif
ied liposomes, which are known to be long-circulating. These liposomes
were injected i.v. into Balb/c mice bearing Meth A sarcoma, and tumor
regression and survival time were monitored after irradiation with la
ser light. Tumor regression and complete curing of tumor (80% cure rat
e by the treatment with 6 mg/kg BPD-R?IA) were observed when long circ
ulating liposomalized BPD-MA was injected and laser-irradiated. In con
trast, only a 20% cure rate was obtained when the animals were treated
with BPD-MA solution or BPD-MA entrapped in conventional liposomes. T
hese results suggest that a long-circulating liposomal formulation of
photo-sensitive agents is useful for PDT.